enGene Therapeutics (ENGN) Total Debt (2022 - 2026)
enGene Therapeutics (ENGN) recorded Total Debt of $25.35 million in fiscal Q3 2026 (quarter ended Jul 31, 2026), up 9.7% from $23.12 million a year earlier and up 1.0% from the prior quarter.
enGene Therapeutics (ENGN) Total Debt (2022 - 2026) Analysis & Trends
At the end of FY2025 (ended Oct 31, 2025), enGene Therapeutics reported Total Debt of $23.33 million, up 0.7% from FY2024.
- Annual Total Debt has a three-year compound annual growth rate of 28.8% (FY2022 to FY2025).
- Across earlier fiscal years, Total Debt came in at $23.17 million in FY2024 (+137.0%), $9.78 million in FY2023 (-10.4%) and $10.91 million in FY2022.
- The fiscal Q3 2026 figure is the highest quarterly Total Debt since fiscal Q3 2023.
- On a year-over-year basis, Total Debt has increased for eight consecutive quarters, with growth averaging 21.1% over the last eight quarters.
- Peak year-over-year performance for Total Debt in the last five years was growth of 137.0% in fiscal Q4 2024, against a decline of 42.6% in fiscal Q3 2024 at the low end.
- Per Business Quant, the preceding three fiscal quarters came in at $25.1 million (Q2 2026), $24.92 million (Q1 2026) and $23.33 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 54.91 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 44.65 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 70.82 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 53.91 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 9.59 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 32.35 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 57.30 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 26.25 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 63.19 Bn |
| 10 | enGene Therapeutics | 105.88 Mn | -888.59 Mn | - | 25.35 Mn |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 25.35 Mn |
| Apr 30, 2026 | 25.10 Mn |
| Jan 31, 2026 | 24.92 Mn |
| Oct 31, 2025 | 23.33 Mn |
| Jul 31, 2025 | 23.12 Mn |
| Apr 30, 2025 | 23.59 Mn |
| Jan 31, 2025 | 23.39 Mn |
| Oct 31, 2024 | 23.17 Mn |
| Jul 31, 2024 | 22.95 Mn |
| Apr 30, 2024 | 22.73 Mn |
| Jan 31, 2024 | 22.53 Mn |
| Oct 31, 2023 | 9.78 Mn |
| Jul 31, 2023 | 39.99 Mn |
| Oct 31, 2022 | 10.91 Mn |
enGene Therapeutics Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=ENGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "ENGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=ENGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();